Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Does Ph'-negative chronic myeloleukemia exist?].

L I Iavorkovskiĭ, L L Iavorkovskiĭ

    Gematologiia I Transfuziologiia
    |November 1, 1989
    PubMed
    Summary

    Most patients diagnosed with Philadelphia chromosome-negative chronic myeloleukemia (CML) actually have other myeloproliferative disorders. Genetic analysis reveals that typical CML markers are often masked or absent in these cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Parvovirus B19 (PV-B19) and the human diseases it causes].

    Terapevticheskii arkhiv·1995
    Same author

    [The treatment of acute promyelocytic leukemia with retinoic acid].

    Terapevticheskii arkhiv·1994
    Same author

    [The Ph+ chromosome in acute leukemias (a review of the research on the molecular restructuring of the BCR gene)].

    Gematologiia i transfuziologiia·1993
    Same author

    [Reversibility of the development of malignant lymphoma with 7-years of leukemization, associated with the development of chronic myeloleukemia].

    Gematologiia i transfuziologiia·1991
    Same author

    [B12 (folic)-deficient anemia in a diabetic patient receiving buformin long term].

    Vrachebnoe delo·1991
    Same author

    [Malignant lymphoma with "hairy" lymphocytes in the blood and splenomegaly--a new variant of lymphoproliferative diseases].

    Gematologiia i transfuziologiia·1990

    Area of Science:

    • Hematology
    • Oncology
    • Cytogenetics

    Context:

    • Chronic Myeloid Leukemia (CML) diagnosis traditionally relies on specific cytogenetic markers.
    • Philadelphia chromosome-negative (Ph'-negative) cases present diagnostic challenges.
    • Distinguishing Ph'-negative CML from other myeloproliferative neoplasms (MPNs) is crucial for appropriate treatment.

    Purpose:

    • To analyze clinico-hematologic data in patients with suspected Ph'-negative CML.
    • To investigate the cytogenetic and molecular-genetic profiles of these patients.
    • To clarify the diagnostic criteria for Ph'-negative CML.

    Summary:

    • Detailed analysis indicates most patients with unchanged chromosome 22 and "Ph'-negative CML" have alternative MPNs, frequently chronic myelomonocytic leukemia.
    • In some CML cases, the Ph' chromosome is masked by translocations.
    • The molecular-genetic marker (bcr/c-abl fusion gene) can be detected on various chromosomes even with an unchanged chromosome 22, while typical cytogenetic and molecular changes are absent in rare typical CML cases.

    Impact:

    • Revises the understanding of Ph'-negative CML diagnosis.
    • Highlights the importance of comprehensive genetic analysis beyond standard cytogenetics.
    • Suggests a need for further research in this patient cohort to refine diagnostic pathways and therapeutic strategies.

    Related Experiment Videos